COMPLETED

Yoga Intervention for the Improvement of Cancer-Related Stress in Cancer Survivors

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This clinical trial develops and test a yoga intervention in improving cancer-related stress in cancer survivors. The online hatha yoga intervention of breathing and movement incorporates both restorative poses, breathing techniques, guided meditation and may reduce stress levels and improve overall quality of health in cancer survivors.

Official Title

Influence of Yoga on Cancer-Related Stress in Cancer Survivors

Quick Facts

Study Start:2021-11-11
Study Completion:2024-06-18
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT04754529

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age \>= 18 years of age
  2. * Have been diagnosed with a cancer and have finished treatment
  3. * Have been cleared for physical activity by a physician or nurse practitioner (physician or nurse practitioner name and date clearance received)
  4. * Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
  1. * Unwilling or unable to complete the assessment in English
  2. * Are pregnant or nursing
  3. * Are unwilling or unable to follow protocol requirements
  4. * Have skeletal instabilities and/or cardio-pulmonary comorbidities
  5. * Have any condition which in the investigator's opinion deems the subject an unsuitable candidate to participate in this study

Contacts and Locations

Principal Investigator

Kathryn Glaser
PRINCIPAL_INVESTIGATOR
Roswell Park Cancer Institute

Study Locations (Sites)

Roswell Park Cancer Institute
Buffalo, New York, 14263
United States

Collaborators and Investigators

Sponsor: Roswell Park Cancer Institute

  • Kathryn Glaser, PRINCIPAL_INVESTIGATOR, Roswell Park Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-11-11
Study Completion Date2024-06-18

Study Record Updates

Study Start Date2021-11-11
Study Completion Date2024-06-18

Terms related to this study

Additional Relevant MeSH Terms

  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm